Join
Live feed
·
INSIDERFilingvia Quantisnow
Monte Rosa Therapeutics Inc. logo

Chief Scientific Officer Townson Sharon was granted 35,000 shares and sold $47,861 worth of shares (3,155 units at $15.17), increasing direct ownership by 88% to 67,845 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLUE (Monte Rosa Therapeutics Inc.) and more on Quantisnow.